TrialMedical oncology (Northwood, London, England)2012

Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥ 10 g/dL: an exploratory analysis of a phase 3 trial.

Jean-Luc Canon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.